Home > Insider Trading > Filing (0001012975-10-000373)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1024520	World Heart Corp	WHRT	Electromedical & Electrotherapeutic Apparatus (3845)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1192212	Philippe Chambon	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1231092	James Niedel	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1247851	Ronald Hunt	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1253170	Srinivas Akkaraju	C/O New Leaf Ventures 2500 Sand Hill Road, Suite 203 Menlo Park CA 94025	No	No	Yes	No
1340806	K Vijay Lathi	C/O New Leaf Ventures 2500 Sand Hill Road, Suite 203 Menlo Park CA 94025	No	No	Yes	No
1441439	New Leaf Ventures Ii, L.p.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1441857	New Leaf Venture Management Ii, L.l.c.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1441858	New Leaf Venture Associates Ii, L.p.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-19	2,341,920	$2.14	6,063,603	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (right to buy)	Acquisiton	2010-10-19	2,341,920	$2.14	2,341,920	$2.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,341,920	2010-10-19	2015-10-19	No	4	P	Direct

Footnotes

Represents the per unit purchase price of a share of common stock and a five-year warrant to purchase one share of common stock.
The securities are directly held by New Leaf Ventures II, L.P. ("NLV II") and indirectly held by New Leaf Venture Associates II, L.P. ("NLV Associates"), the sole general partner of NLV II, New Leaf Venture Management II, L.L.C. ("NLV Management"), the sole general partner of NLV Associates, and the individual managers of NLV Management (NLV Associates, NLV Management and the individual managers of NLV Management each, an "Indirect Reporting Person"). The individual managers of NLV Management filing jointly with NLV II, NLV Associates and NLV Management are Philippe O. Chambon, James Niedel, Vijay Lathi, Ronald Hunt and Srinivas Akkaraju. Each Indirect Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NLV II shares and warrants in which such Indirect Reporting Person has no actual pecuniary interest therein.